We conducted a scoping review to map and critically examine the knowledge, perceptions and utilization of generics and biosimilars, among physicians, pharmacists, patients, the general population, and other stakeholders from LAC.
Keywords: Biosimilar Pharmaceuticals; Drugs; Health Expenditures; Latin America; Policy.